Interpretation of guidelines for the diagnosis and treatment of breast cancer during the COVID-19 outbreak
10.3969/j.issn.1000-8179.2020.08.404
- VernacularTitle: 《新型冠状病毒肺炎疫情期间乳腺癌合理化诊疗指南》解读
- Author:
Lixi LI
1
Author Information
1. Department of Oncology, National Cancer Center, National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College
- Publication Type:Journal Article
- Keywords:
Breast neoplasms;
Corona virus disease 2019 (COVID-19);
Diagnosis;
Guidelines;
Treatment
- From:
Chinese Journal of Clinical Oncology
2020;47(8):379-383
- CountryChina
- Language:Chinese
-
Abstract:
The worldwide outbreak of a novel coronavirus (COVID-19) in December 2019 significantly affected the routine diagnosis and treatment of breast cancer due to resource and staffing constraints. In addition, breast cancer patients have poor immunity and are, therefore, more susceptible to COVID-19. If they are infected, the risk of severe illness is extremely high. Therefore, finding a balance between the effective prevention and control of COVID-19 and diagnosing and treating patients with breast cancer is a significant clinical issue during the pandemic. Therefore, the National Cancer Quality Control Center Breast Cancer Expert Committee brought together experts to urgently compile a "Guideline for the Rationalized Diagnosis and Treatment of Breast Cancer during the Outbreak of Corona Virus Disease 2019". Here, we will interpret the core recommendations in the guideline for breast cancer diagnosis and treatment.
